Cyclosporine a regulates pro-inflammatory cytokine production in ulcerative colitis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 63, Issue 1, 2014, Pages 53-63

  Steiner, Stefanie ^a   Daniel, Carolin ^b   Fischer, Anika ^a   Atreya, Imke ^a   Hirschmann, Simon ^a   Waldner, Maximilian ^a   Neumann, Helmut ^a   Neurath, Markus ^a   Atreya, Raja ^a   Weigmann, Benno ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Apoptosis; Cyclosporine A; IBD; IL 13; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; CASPASE 8; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; NECROSTATIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CASP8 PROTEIN, HUMAN; CYCLOSPORIN;

ADULT; AGED; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; ULCERATIVE COLITIS; ADOLESCENT; CASE CONTROL STUDY; COLITIS, ULCERATIVE; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; T LYMPHOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CASE-CONTROL STUDIES; CASPASE 8; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; COLITIS, ULCERATIVE; CROHN DISEASE; CYCLOSPORINE; CYTOKINES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-13; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84926632207     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-014-0309-7     Document Type: Article

References (53)

1. Andersson J, Nagy S, Groth CG et al (1992) Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a singlecell level. Immunology 75:136-142
2. Atreya R, Zimmer M, Bartsch B et al (2011) Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14? macrophages. Gastroenterology 141:2026-2038
3. Becker C, Watson AJ, Neurath MF (2013) Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 144:283-293
4. Boirivant M, Pica R, DeMaria R et al (1996) Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Clin Invest 98:2616-2622
5. Brynskov J, Freund L, Norby Rasmussen S et al (1991) Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn’s disease. Scand J Gastroenterol 26:689-695
6. Bunikowski R, Staab D, Kussebi F et al (2001) Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol 12:216-223
7. Camoglio L, Te Velde AA, Tigges AJ et al (1998) Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 4:285-290
8. Chang KH, Burke JP, Coffey JC (2013) Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis 28:287-293
9. Chi W, Yang P, Zhu X et al (2010) Production of interleukin-17 in Behcet’s disease is inhibited by cyclosporin A. Mol Vis 16:880-886
10. Coffey JC, Rowan F, Burke J et al (2009) Pathogenesis of and unifying hypothesis for idiopathic pouchitis. Am J Gastroenterol 104:1013-1023
11. Del Zotto B, Mumolo G, Pronio AM et al (2003) TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn’s disease and ulcerative colitis. Clin Exp Immunol 134:120-126
12. Demchenko AP (2012) The change of cellular membranes on apoptosis: fluorescence detection. Exp Oncol 34:263-268
13. Desreumaux P, Brandt E, Gambiez L et al (1997) Distinct cytokine patterns in early and chronic ileal lesions of Crohn’s disease. Gastroenterology 113:118-126
14. D’Haens G, Lemmens L, Geboes K et al (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120:1323-1329
15. Doering J, Begue B, Lentze MJ et al (2004) Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn’s disease. Gut 53:1632-1638
16. Feagan BG, McDonald JW, Rochon J et al (1994) Low-dose cyclosporine for the treatment of Crohn’s disease. The canadian Crohns relapse prevention trial investigators. N Engl J Med 330:1846-1851
17. Fujino S, Andoh A, Bamba S et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70
18. Fuss IJ, Neurath M, Boirivant M et al (1996) Disparate CD4? lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157:1261-1270
19. Granelli-Piperno A (1988) In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A. J Exp Med 168:1649-1658
20. Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911
21. Gunther C, Martini E, Wittkopf N et al (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477:335-339
22. Harness J, Pender MP, McCombe PA (2001) Cyclosporin A treatment modulates cytokine mRNA expression by inflammatory cells extracted from the spinal cord of rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein. J Neurol Sci 187:7-16
23. Heller F, Florian P, Bojarski C et al (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129:550-564
24. Hering NA, Fromm M, Schulzke JD (2012) Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol 590(5):1035-1044
25. Hoffmann U, Heilmann K, Hayford C et al (2007) CD44v7 ligation downregulates the inflammatory immune response in Crohn’s disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell Death Differ 14:1542-1551
26. Kountouras J, Zavos C, Chatzopoulos D (2004) Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. J Cell Mol Med 8:317-328
27. Lee EW, Seo J, Jeong M et al (2012) The roles of FADD in extrinsic apoptosis and necroptosis. BMB Rep 45:496-508
28. Lichtiger S, Present DH, Kornbluth A et al (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841-1845
29. MacDonald TT, Monteleone G (2001) IL-12 and Th1immune responses in human Peyer’s patches. Trends Immunol 22:244-247
30. Mandai Y, Takahashi D, Hase K et al (2013) Distinct roles for CXCR6 and CXCR6 CD4 T cells in the pathogenesis of chronic colitis. PLoS ONE 8:e65488
31. Mannon P, Reinisch W (2012) Interleukin 13 and its role in gut defence and inflammation. Gut 61:1765-1773
32. Marek A, Brodzicki J, Liberek A et al (2002) TGF-beta (transforming growth factor-beta) in chronic inflammatory conditions—a new diagnostic and prognostic marker? Med Sci Monit 8:145-151
33. Matsuoka K, Inoue N, Sato T et al (2004) T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease. Gut 53:1303-1308
34. McCombe PA, Harness J, Pender MP (1999) Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neuroimmunol 97:60-69
35. Meijssen MA (1998) Cyclosporine and inflammatory bowel disease: buying time. Mediat Inflamm 7:145-147
36. Melgar S, Yeung MM, Bas A et al (2003) Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol 134:127-137
37. Mudter J, Neurath MF (2007) Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 56:293-303
38. Neurath MF, Finotto S, Fuss I et al (2001) Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol 22:21-26
39. Pino-Lagos K, Michea P, Sauma D et al (2010) Cyclosporin A-treated dendritic cells may affect the outcome of organ transplantation by decreasing CD4 ? CD25 ? regulatory T cell proliferation. Biol Res 43:333-337
40. Rafiq K, Bullens DM, Kasran A et al (2000) Differences in regulatory pathways identify subgroups of T cell-derived Th2 cytokines. Clin Exp Immunol 121:86-93
41. Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK (2008) Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14:4280-4288
42. Shale M, Schiering C, Powrie F (2013) CD4? T-cell subsets in intestinal inflammation. Immunol Rev 252:164-182
43. Shen B (2013) Pouchitis: what every gastroenterologist needs to know. Clin Gastroenterol Hepatol 11:1538-1549
44. Siegel CA, Sands BE (2005) Review article: practical management of inflammatory bowel disease patients taking immunomodulators. Aliment Pharmacol Ther 22:1-16
45. Stange EF, Modigliani R, Pena AS et al (1995) European trial of cyclosporine in chronic active Crohn’s disease: a 12-month study. The European Study Group. Gastroenterology 109:774-782
46. ten Hove T, van Montfrans C, Peppelenbosch MP et al (2002) Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn’s disease. Gut 50:206-211
47. Tiede I, Fritz G, Strand S et al (2003) CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4? T lymphocytes. J Clin Invest 111:1133-1145
48. Tsuda K, Yamanaka K, Kitagawa H et al (2012) Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells. PLoS ONE 7:e31465
49. Van Assche G, D’Haens G, Noman M et al (2003) Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125:1025-1031
50. Van den Brande JM, Koehler TC, Zelinkova Z et al (2007) Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn’s disease. Gut 56:509-517
51. Vivinus-Nebot M, Frin-Mathy G, Bzioueche H et al (2014) Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 63:744-752
52. Wlodkowic D, Telford W, Skommer J et al (2011) Apoptosis and beyond: cytometry in studies of programmed cell death. Methods Cell Biol 103:55-98
53. Zheng B, Morgan ME, van de Kant HJ et al (2013) Transcriptional modulation of pattern recognition receptors in acute colitis in mice. Biochim Biophys Acta 1832:2162-2172